Search Result "class III β-tubulin"
Class III β -Tubulin (TUBB3): More than a Biomarker in Solid Tumors?
Journal: Current Molecular Medicine
Volume: 11 Issue: 9 Year: 2011 Page: 726-731
Author(s): M. Mariani, S. Shahabi, S. Sieber, G. Scambia, C. Ferlini
Targeting βIII-Tubulin in Glioblastoma Multiforme: From Cell Biology and Histopathology to Cancer Therapeutics
Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 11 Issue: 8 Year: 2011 Page: 719-728
Author(s): Christos D. Katsetos, Pavel Draber, Maria Kavallaris
Amyloid-Beta Peptide 1-42 Causes Microtubule Deregulation through N-methyl-D-aspartate Receptors in Mature Hippocampal Cultures
Journal: Current Alzheimer Research
Volume: 9 Issue: 7 Year: 2012 Page: 844-856
Author(s): Sandra I. Mota,Ildete L. Ferreira,Claudia Pereira,Catarina R. Oliveira,A. Cristina Rego
Evaluation of Differentiation Quality of Several Differentiation Inducers of Bone Marrow-Derived Mesenchymal Stem Cells to Nerve Cells by Assessing Expression of Beta-tubulin 3 Marker: A Systematic Review
Journal: Current Stem Cell Research & Therapy
Volume: 16 Issue: 0 Year: 2021 Page: 1-11
Author(s): Mohsen Karami Fath,Farhad Zahedi,Zahra Sadat Hashemi,Saeed Khalili
Vinorelbine in Cancer Therapy
Journal: Current Drug Targets
Volume: 13 Issue: 8 Year: 2012 Page: 1065-1071
Author(s): Anna Capasso
Human Sirtuins: An Overview of an Emerging Drug Target in Age-Related Diseases and Cancer
Journal: Current Drug Targets
Volume: 14 Issue: 6 Year: 2013 Page: 653-661
Author(s): Alessandra Donadini, Camillo Rosano, Lamberto Felli, Marco Ponassi
Inhibitors of NAD+ Dependent Histone Deacetylases (Sirtuins)
Journal: Current Pharmaceutical Design
Volume: 14 Issue: 6 Year: 2008 Page: 562-573
Author(s): Manfred Jung, Robert C. Neugebauer, Wolfgang Sippl
“Virostatics” as a Potential New Class of HIV Drugs
Journal: Current Pharmaceutical Design
Volume: 10 Issue: 3 Year: 2004 Page: 4103-4120
Author(s): L. M. Kelly, J. Lisziewicz, F. Lori
Second Generation Taxanes: from the Natural Framework to the Challenge of Drug Resistance
Journal: Current Medicinal Chemistry - Anti-Cancer Agents
Volume: 3 Issue: 2 Year: 2003 Page: 133-138
Author(s): Cristiano Ferlini, Iwao Ojima, Mariagrazia Distefano, Daniela Gallo, Antonella Riva, Paolo Morazzoni, Ezio Bombardelli, Salvatore Mancuso, Giovanni Scambia
Anti-Cancer Compounds Targeted to VDAC: Potential and Perspectives
Journal: Current Medicinal Chemistry
Volume: 24 Issue: 40 Year: 2017 Page: 4447-4469
Author(s): Simona Reina,Vito De Pinto